Forecasting Future Sales, From the Bottom Up

, ,
Forecasting Future Sales, From the Bottom Up An AI/ML approach to precision forecasting for the Pharma industry Much goes into the setting of sales goals and strategizing on how to achieve them. Sales estimates are projected based on a complex…

How to grasp a significant stake of your pharma market?

, , ,
How to grasp a significant stake of your pharma market? From effective strategy to efficient execution The pharmaceutical marketing landscape is extremely dynamic and ever-evolving, with shifts drastically influencing how pharmaceutical companies…

Adieu 2020. Looking Forward to a saner 2021

By Doron Aspitz, Verix CEO. 2020 is definitely not an easy year to summarize, neither personally nor professionally. I have mixed feelings about this year. For Verix, the year that started with a feeling that a bombshell had been dropped on…

Unleashing the power of AI/ML by upskilling business users

The emerging role of citizen data scientist in Pharma Commercial Operations.   Pharma and biotech companies, especially those introducing first-in-class Specialty & Oncology drugs, with added complexity such as novel mechanisms…
Failure blog post

Why are so many AI projects doomed for failure?

The elephant in the room is actually human By Shahar Cohen, PhD, Head of Verix AI Lab.   One of my first data science projects sought to improve the targeting process of a sales organization. Before we came in, sales reps were expected…

Bottom-up or Top-down Forecasting - Which Model Best Fits Your Needs?

Understanding HCPs’ prescribing behavior Vs. analyzing market trends. Demand forecast is key for sales and operations planning in the pharmaceutical industry. Naturally, a lot of time, money, and effort are invested in developing forecast…

Turn red roses into red alerts- How to detect anomalies before they affect your business

Have You Noticed There’s a Rosebush in Every Vineyard? Why and what can we learn from it? The picturesque 12th century Chateau Clos de Vougeot in Burgundy was famous for its prolific vineyards, maintained by local monks.  These monks realized…
Data: The Unlikely Star in a New ADHD Drug Launch

Data: The Unlikely Star in a New ADHD Drug Launch

In the whirlwind months leading up to a drug launch, data is just one of many concerns on pharma companies’ minds. But even before a new treatment gets into the hands of patients, companies with the right kind of advanced analytics…

How to Ride the Data Wave When Launching a New Drug

Some experts say that 50% of drug launches fail. Others say it’s as high as 90%. From my perspective, judging launches in such black-and-white terms isn’t particularly useful. Instead, I look at the market performance of a new drug…